Lexicon Pharmaceuticals Inc (LXRX):企業の財務・戦略的SWOT分析

◆英語タイトル:Lexicon Pharmaceuticals Inc (LXRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH66468FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Lexicon Pharmaceuticals Inc (LXRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lexicon Pharmaceuticals Inc (Lexicon) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of innovative treatments for human diseases. The company has advanced multiple drug candidates into clinical development and has clinical-stage drug program sotagliflozin for heart failure and type 1 diabetes. Its clinical and preclinical development programs, LX2761 and LX9211 are focused at treating diabetes and neuropathic pain respectively. Lexicon has a laboratory in Texas. It has business collaborations with several pharmaceutical and biotechnology companies. Lexicon is headquartered at The Woodlands, Texas, the US.

Lexicon Pharmaceuticals Inc Key Recent Developments

Mar 10,2021: Lexicon Pharmaceuticals reports fourth quarter and full-year 2020 financial results and provides clinical update
Mar 04,2021: Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call and Webcast on March 10, 2021
Oct 29,2020: Lexicon Pharmaceuticals reports third quarter 2020 financial results and provides clinical update
Jul 30,2020: Lexicon Pharmaceuticals reports second quarter 2020 financial results and provides a business update
Apr 27,2020: Lexicon Pharmaceuticals reports first quarter 2020 financial results and provides a business update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Lexicon Pharmaceuticals Inc – Key Facts
Lexicon Pharmaceuticals Inc – Key Employees
Lexicon Pharmaceuticals Inc – Key Employee Biographies
Lexicon Pharmaceuticals Inc – Major Products and Services
Lexicon Pharmaceuticals Inc – History
Lexicon Pharmaceuticals Inc – Company Statement
Lexicon Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Lexicon Pharmaceuticals Inc – Business Description
Lexicon Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Lexicon Pharmaceuticals Inc – Strengths
Lexicon Pharmaceuticals Inc – Weaknesses
Lexicon Pharmaceuticals Inc – Opportunities
Lexicon Pharmaceuticals Inc – Threats
Lexicon Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 10, 2021: Lexicon Pharmaceuticals reports fourth quarter and full-year 2020 financial results and provides clinical update
Mar 04, 2021: Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call and Webcast on March 10, 2021
Oct 29, 2020: Lexicon Pharmaceuticals reports third quarter 2020 financial results and provides clinical update
Jul 30, 2020: Lexicon Pharmaceuticals reports second quarter 2020 financial results and provides a business update
Apr 27, 2020: Lexicon Pharmaceuticals reports first quarter 2020 financial results and provides a business update
Mar 12, 2020: Lexicon Pharmaceuticals reports fourth quarter and full-year 2019 financial results and provides a business update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Lexicon Pharmaceuticals Inc, Key Facts
Lexicon Pharmaceuticals Inc, Key Employees
Lexicon Pharmaceuticals Inc, Key Employee Biographies
Lexicon Pharmaceuticals Inc, Major Products and Services
Lexicon Pharmaceuticals Inc, History
Lexicon Pharmaceuticals Inc, Subsidiaries
Lexicon Pharmaceuticals Inc, Key Competitors
Lexicon Pharmaceuticals Inc, Ratios based on current share price
Lexicon Pharmaceuticals Inc, Annual Ratios
Lexicon Pharmaceuticals Inc, Annual Ratios (Cont...1)
Lexicon Pharmaceuticals Inc, Annual Ratios (Cont...2)
Lexicon Pharmaceuticals Inc, Interim Ratios
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Lexicon Pharmaceuticals Inc (LXRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Armstrong Bros. Tool Co.:企業の戦略的SWOT分析
    The Armstrong Bros. Tool Co. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • DEKRA e.V.:企業の戦略的SWOT分析
    DEKRA e.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Torm Plc (TRMD A):石油・ガス:M&Aディール及び事業提携情報
    Summary Torm Plc (Torm) is a shipping company serving the oil and gas sector. It offers a range of transportation services through its affiliated companies. The company undertakes transportation of refined oil products such as gasoline, jet fuel, naphtha, gas oil and fuel oil through its product tan …
  • Blueknight Energy Partners LP:企業のM&A・事業提携・投資動向
    Blueknight Energy Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Blueknight Energy Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Clementia Pharmaceuticals Inc (CMTA)-製薬・医療分野:企業M&A・提携分析
    Summary Clementia Pharmaceuticals Inc (Clementia) is a biopharmaceutical company that develops and commercializes orphan drugs and therapies. The company’s palovarotene is used for treatment of muscle tissue disorders such as fibrodysplasia ossificans progressive and other diseases. Its palovarotene …
  • United Services Automobile Association:企業のM&A・事業提携・投資動向
    United Services Automobile Association - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Services Automobile Association Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Devon Energy Corporation (DVN)-石油・ガス分野:企業M&A・提携分析
    Summary Devon Energy Corporation (Devon Energy) is an independent energy company. The company carries out exploration, development, and production of oil, natural gas and natural gas liquids (NGLs). It has its operations in onshore areas of the US and Canada. Devon Energy’s US assets are located in …
  • Tav Havalimanlari Holding AS:戦略・SWOT・企業財務分析
    Tav Havalimanlari Holding AS - Strategy, SWOT and Corporate Finance Report Summary Tav Havalimanlari Holding AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Polpharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Polpharma SA (Polpharma) undertakes the research, manufacture and marketing of generic drugs, prescription drugs and over the counter medications. It provides drugs in cardiology, gastroenterology and neurology areas. The company also manufactures over the counter (OTC) medications, dietary …
  • Daito Trust Construction Co., Ltd.:企業の戦略・SWOT・財務情報
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Spectrum Health System:企業の戦略的SWOT分析
    Spectrum Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SM Energy Company:企業の戦略・SWOT・財務情報
    SM Energy Company - Strategy, SWOT and Corporate Finance Report Summary SM Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • DURECT Corp (DRRX)-製薬・医療分野:企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • PPL Corp (PPL):企業の財務・戦略的SWOT分析
    PPL Corp (PPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Superior Industries International, Inc.:企業の戦略・SWOT・財務情報
    Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • JPMorgan Chase & Co.:企業の戦略・SWOT・財務情報
    JPMorgan Chase & Co. - Strategy, SWOT and Corporate Finance Report Summary JPMorgan Chase & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Burwill Holdings Limited:企業の戦略・SWOT・財務情報
    Burwill Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Burwill Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Take-Two Interactive Software, Inc. (TTWO):企業の財務・戦略的SWOT分析
    Take-Two Interactive Software, Inc. (TTWO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Zimmer Biomet Holdings Inc (ZBH)-製薬・医療分野:企業M&A・提携分析
    Summary Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company with focus on musculoskeletal healthcare. It carries out the design, development, manufacture, and marketing of reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, cr …
  • Danieli & C. Officine Meccaniche SpA:企業の戦略・SWOT・財務分析
    Danieli & C. Officine Meccaniche SpA - Strategy, SWOT and Corporate Finance Report Summary Danieli & C. Officine Meccaniche SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆